Irritable Bowel Syndrome Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Are Sleeping Disorders Associated With Visceral Hypersensitivity in Irritable Bowel Syndrome Patients ?
Condition: Irritable Bowel Syndrome Interventions: Procedure: Barostat procedure; Other: Anxiety and Depression Evaluation; Other: Assessment of sleep quality Sponsor: University Hospital, Rouen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 19, 2019 Category: Research Source Type: clinical trials
Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C
Conditions: Irritable Bowel Syndrome With Constipation; Functional Constipation Interventions: Drug: Irritable Bowel Syndrome with Constipation (IBS-C) participants (LIN-MD-63 completers); Drug: Functional Constipation (FC) participants (LIN-MD-62 and LIN-MD-64 completers): Sponsors: Allergan; Ironwood Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2019 Category: Research Source Type: clinical trials
G-PUR ® for Symptomatic Treatment in Irritable Bowel Syndrome With Diarrhea
Condition: Irritable Bowel Syndrome With Diarrhea (IBS-D) Interventions: Device: 2.0g G-PUR®, oral administration; Device: Placebo, oral administration Sponsor: Glock Health, Science and Research GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2019 Category: Research Source Type: clinical trials
A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Condition: Irritable Bowel Syndrome With Diarrhea Interventions: Drug: ORP-101; Drug: Placebo Sponsors: OrphoMed, Inc.; PPD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2019 Category: Research Source Type: clinical trials
Allogeneic Microbiota-reconstitution (AMR) in Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
Condition: Diarrhea-predominant Irritable Bowel Syndrome Interventions: Procedure: Allogeneic microbiota reconstitution; Procedure: Placebo-Allogeneic microbiota reconstitution Sponsors: University of Ulm; Klinikum Ludwigsburg; Helios Klinikum Krefeld; Charite University, Berlin, Germany; Assign International, Berlin, Germany Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 19, 2019 Category: Research Source Type: clinical trials
